Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Mahfuzul Hassan

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Assistant Professor

1 pubs

  • Antineoplastic Agents
  • Macrocyclic Compounds
  • Histone Deacetylase Inhibitors
  • Carbocyanines
  • Humans
  • Indocyanine Green
  • Infrared Rays
  • Cell Line, Tumor
  • Nanomedicine
  • Nanoparticles
  • MCF-7 Cells

Biography and Research Information

OverviewAI-generated summary

Mahfuzul Hassan's research focuses on developing advanced nanomedicines for cancer therapy. His work involves the synthesis and application of macrocyclic histone deacetylase inhibitors, integrated into ionic nanomedicines designed to respond to near-infrared light. This approach aims to enhance therapeutic efficacy by targeting tumor cells more specifically and potentially reducing side effects.

Hassan collaborates with researchers from the University of Arkansas at Little Rock, including Nawab Ali, Monowar Hossain, Adeolu Oluremi, and Shahedur Rahman, on shared publications. His recent publication in 2026 details the design of these near-infrared-responsive nanomedicines for improved cancer treatment outcomes.

Metrics

  • Publications: 1

Positions

  • Assistant Professor 2023–present
    Philander Smith College Department of Chemistry ORCID
  • Assistant Professor publications 2026
    Philander Smith College ORCID

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

8 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics